Endocrine Abstracts

Treatment of transgender patients has gained increasing importance in outpatient endocrinological care due to a steadily rising influx of patients in recent years. Many gaps in knowledge regarding hormonal therapy have been filled in recent years thanks to a growing body of literature based on larger cohort studies. Nowadays therapy can be regarded as safe and effective. While puberty arrest and peripubertal hormone treatment in transgender youth has gained growing acceptance in recent years, some questions still remain unsolved but will hopefully be answered in years to come, following the steadily growing knowledge and experience in this area. This talk summarizes the current knowledge on risks and benefits of endocrine treatment in transgender individuals and should open discussion based on patient cases on questions such as optimal treatment monitoring, the use of progestins/progesterone, fertility preservation, relevant comorbidities and ideal hormone treatment across the lifespan.